MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 461400 | Name: Ciclonicate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ciclonicate is a vasodilator.

Chemical Structure

Ciclonicate
Ciclonicate
CAS#53449-58-4

Theoretical Analysis

MedKoo Cat#: 461400

Name: Ciclonicate

CAS#: 53449-58-4

Chemical Formula: C15H21NO2

Exact Mass: 247.1572

Molecular Weight: 247.33

Elemental Analysis: C, 72.84; H, 8.56; N, 5.66; O, 12.94

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Ciclonicate; Cortofludan; Elastan; Rolil; Vasargil; P-350; P 350; P350;
IUPAC/Chemical Name
(1R,5S)-3,3,5-trimethylcyclohexyl nicotinate
InChi Key
GQSGZTBDVNUIQS-DGCLKSJQSA-N
InChi Code
InChI=1S/C15H21NO2/c1-11-7-13(9-15(2,3)8-11)18-14(17)12-5-4-6-16-10-12/h4-6,10-11,13H,7-9H2,1-3H3/t11-,13-/m1/s1
SMILES Code
O=C(C1=CC=CN=C1)O[C@H]2CC(C)(C)C[C@H](C)C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 247.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Licata G, Pinto A, Parrinello G, Salli L, Indovina I. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs]. Clin Ter. 1985 Mar 31;112(6):503-13. Italian. PubMed PMID: 4017475. 2: Gregoratti L, Crespi B, Groothold G, Fuligni E, Ghiringhelli L. [Treatment of arteriosclerotic peripheral vascular diseases with ciclonicate]. Minerva Cardioangiol. 1982 Nov;30(11):659-68. Italian. PubMed PMID: 7155375. 3: Feliciotti F, De Carolis G, Mariotti C, Mingolla F. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II]. Ann Ital Chir. 1983;55(5):493-7. Italian. PubMed PMID: 6673630. 4: Faini D, Pagella PG, Bellavite O, Turba C. Long-lasting antilipolytic action of cyclonicate in rats. Farmaco Prat. 1981 Oct;36(10):478-85. PubMed PMID: 7308421. 5: Alvisi V, Strozzi C. [Clinical evaluation of cyclonicate in atherosclerotic coronary arteriopathy]. Minerva Cardioangiol. 1982 Apr;30(4):209-11. Italian. PubMed PMID: 7088305. 6: Tessari F, Caparrotta L, Gaion RM, Fassina G. Effect of cyclonicate, a new hypolipemic drug, on lipolysis in vitro. Farmaco Sci. 1981 Dec;36(12):1029-36. PubMed PMID: 6274681.